только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 10 / 10
Страница 289 / 290

Литература

Внимание! Часть функций, например, копирование текста к себе в конспект, озвучивание и т.д. могут быть доступны только в режиме постраничного просмотра.Режим постраничного просмотра
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

72.  Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review / A. J. Gonzalez-Perez [et al.] // J. Allergy Clin. Immunol. 2010. Vol. 125, N 5. P. 1098-1104.

  1. Park, H. J. Factors associated with shock in anaphylaxis / H. J. Park , S.H. Kim // Am. J. Emerg. Med. 2012. Vol. 30, N 9. P. 1674-1678.
  2. Symptom profile and risk factors of anaphylaxis in Central Europe / M. Worm [et al.] // Allergy. 2012. Vol. 67, N 5. P. 691-698.
  3. Anaphylaxis in emergency department patients 50 or 65 years or older / R. L. Campbell. // Ann. Allergy Asthma Immunol. 2011. Vol. 106, N 5. P. 401-406.
  4. Allergy and the cardiovascular system / M. Triggiani [et al.] // Clin. Exp. Immunol. 2008. Vol. 153, Suppl. 1. P. 7-11.
  5. Systemic mastocytosis - a systematic review / Ch. L. Andersen [et al]. // Dan. Med. J. 2012. Vol. 59, N 3. P. A4397.
  6. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper / P. Bonadonna [et al.] // Allergy. 2015. Vol. 70, N 7. P. 755-763.
  7. Tracy, J. M. Insect anaphylaxis: where are we? The stinging facts 2012 / J. Tracy, F. S. Khan , J. G. Demain // Curr. Opin. Allergy Clin. Immunol. 2012. .Vol. 12, N 4. P. 400-405.
  8. Worm, M. Causes and risk factors for anaphylaxis / M. Worm, M. Babina, S. Hompes // J. Dtsch. Dermatol. Ges. 2013. Vol. 11, N 1. P. 44-50.
  9. Vadas, P. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis / P. Vadas, B. Perelman, G. Liss // J. Allergy Clin. Immunol. 2013. Vol. 131, N 1. P. 144-149.
  10. Ponvert, C. Allergic and non-allergic hypersensitivity to non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory drugs in children: epidemiology, clinical aspects, pathophysiology, diagnosis and prevention / C. Ponvert // Arch. Pediatr. 2012. Vol. 19, N 5. P. 556-560.
  11. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis and anti-tumor immunotherapy/ D. A. Mancardi [et al.] // Blood. 2013. Vol. 121, N 9. P. 1563-1573.
  12. Емельянов, А. В. Анафилактический шок / А. В. Емельянов. Москва, 2005. 28 с. (Российский аллергологический журнал ; N 3, прил.).
  13. Anaphylaxis / ed. J. Ring (Munich). Basel Karger, 2010. 228p. (Chem Immunol Allergy ; vol. 95.).
  14. Nonallergic drug hypersensitivity reactions / K. Farnam [et al.] // Int. Arch. Allergy Immunol. 2012. Vol. 159, N 4. P. 327-345.
  15. How can we better classify NSAID hypersensitivity reactions? - validation from a large database / S. Caimmi [et al.] // Int. Arch. Allergy Immunol. 2012. Vol. 159, N 3. P. 306-312.
  16. Povesi Dascola, C. Exercise-induced anaphylaxis: a clinical view / Dascola C. Povesi ,C. Caffarelli // Ital. J. Pediatr. 2012. Vol. 38. P. 43.
  17. Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement / L. Ansley [et al.] // Allergy. 2015. Vol. 70, N 10. P. 1212-1221.
  18. Greenberger, P. A. Idiopathic anaphylaxis / P. A. Greenberger // Immunol. Allergy Clin. North Am. 2007. Vol. 27, N 2. P. 273-293.
  19. Blatman, K. H. Idiopathic anaphylaxis. Ch. 25 / K. N. Blatman, A. M. Ditto // Allergy and Asthma Proceedings / ed. by P. A. Greenberger, L. C. Grammer. 2012. Vol. 33, N 3, Suppl. P. S84-S87.
  20. The cytokine interleukin-33 mediates anaphylactic shock / P. N. Pushparaj [ et al.] // Proc. Natl. Acad. Sci. U S A. 2012. Vol. 109, N 34. P. 13877.
  21. Glowania, A. Management of anaphylaxis. Part 1. Causes and pathophysiology / A. Glowania, U. Goebel, L. Klimek // HNO. 2012. Vol. 60, N 11. P. 1019-1028.
  22. Freichel, M. The Role of TRP Proteins in Mast Cells / M. Freichel, J. Almering, V. Tsvilovskyy // Front. Immunol. 2012. Vol. 3. P. 150.
  23. Smith, P. K. Transient Receptor Potentials (TRPs) and Anaphylaxis / P. K. Smith, B. Nilius // Curr Allergy Asthma Rep. 2013. Vol. 13, N 1. P. 93-100.
  24. Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients / R. L. Campbell [et al.] // J. Allergy Clin. Immunol. 2012. Vol. 129, N 3. P. 748-752.
  25. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida / L. Harduar-Morano [et al.] // J. Allergy Clin. Immunol. 2010. Vol. 126, N 1. P. 98-104.
  26. Arnold, J. J. Anaphylaxis: Recognition and Management / J. J. Arnold, P. M. Williams // Am. Fam. Physician. 2011. Vol. 84, N 10. P. 1111-1118.
  27. Epidemiologyof anaphylaxis among children and adolescents enrolled in a health maintenance organization / K. Bohlke [et al.] // J. Allergy Clin. Immunol. 2004. Vol. 113, N 3. P. 536-542.

100.                     Brown, S. G. Clinical features and severity grading of anaphylaxis / S. G. Brown // J. Allergy Clin. Immunol. 2004. Vol. 114, N 2. P. 371-376.

  1. Symptom profile and risk factors of anaphylaxis in Central Europe / M. Worm [et al.] // Allergy. 2012. Vol. 67, N 5. P. 691-698.
  2. Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries / S. Hompes [et al.] // Pediatr. Allergy Immunol. 2011. Vol. 22, N 6. P. 568-574.
  3. Paediatric emergency department anaphylaxis: different patterns from adults / S. C. Braganza // Arch. Dis. Child. 2006. Vol. 91, N 2. P. 159-163.
  4. Anaphylaxis and reactions to foods in children - a population-based case study of emergency department visits / M. Vetander [et al.] // Clin. Exp. Allergy. 2012. Vol. 42, N 4. P. 568-577.
  5. Pumphrey, R. S. Lessons for management of anaphylaxis from a study of fatal reactions / R. S. Pumphrey // Clin. Exp. Allergy. 2000. Vol. 30, N 8. P. 1144-1150.
  6. Global classification and coding of hypersensitivity diseases - An EAACI - WAO survey, strategic paper and review/ P. Demoly [et al.] // Allergy. 2014. Vol. 69, N 5. P. 559-570.
  7. Ellis, A. K. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients / A. K. Ellis, J. H. Day // Ann. Allergy Asthma Immunol. 2007. Vol. 98, N 1. P. 64-69.
  8. Lee, J. M. Biphasic anaphylactic reactions in pediatrics / J. M. Lee, D. S. Greenes // Pediatrics. 2000. Vol. 106, N 4. P. 762-766.
  9. Lieberman, P. Biphasic anaphylactic reactions / P. Lieberman // Ann. Allergy Asthma Immunol. 2005. Vol. 95, N 3. P. 217-226.
  10. Clinical predictors for biphasic reactions in children presenting with anaphylaxis / S. Mehr [et al.] // Clin. Exp. Allergy. 2009. Vol. 39, N 9. P. 1390-1396.
  11. GLORIA Module 8 : Anaphylaxis   WAO Expert Panel R. F. Lockey, M. A. Kaliner, F. E. R. Simons, C. Motala, B. Lanier, Additional contributor:  A. Sheikh
  12. Simons, F. E. Anaphylaxis pathogenesis and treatment / F. E. Simons // Allergy. 2011. Vol. 66, Suppl. 95. P. 31-34.
  13. Systemic mastocytosis - a systematic review / C. L. Andersen [et al.] // Dan. Med. J. 2012. Vol. 59. N 3. P. A4397.

114.                     Predictors of hospital admission for food-related allergic reactions that present to the emergency department / A. Banerji [et al.]. // Ann. Allergy Asthma Immunol. 2011. Vol. 106, N 1. P. 42-48.

  1. Rutkowski, K. Anaphylaxis: current state of knowledge for the modern physician / K. Rutkowski, S. Dua, S. Nasser // Postgrad. Med. J. 2012. Vol. 88, N 1042. P. 458-464.
  2. Lieberman, P. Anaphylaxis and anaphylactoid reactions / P. Lieberman // Allergy. Middleton’s Principles and Practice. 2nd. ed./ Y. Donald [et al.]. USA: Mosby Inc, 2003. P. 1497-1522.

117.                     Da Broi U. Post-mortem diagnosis of anaphylaxis: A difficult task in forensic medicine / Da Broi, C. Moreschi // Forensic Sci. Int. 2011. Vol. 204, N 1-3. P. 1-5.

118.                     Лопатин А. С. Лекарственный анафилактический шок / А. С. Лопатин. Москва : Медицина, 1983. 160 с. (Библиотека практического врача).

  1. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock / A. Sheikh [et al.] // Cochrane Database of Systematic Reviews. 2008. N 4.
  2. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology // A. Muraro [et al.] // Allergy. 2007. Vol. 62, N 8. P. 857-871.
  3. Kirkbright, S. J. Anaphylaxis-recognition and management / S. J. Kirkbright, S. G. Brown // Aust. Fam. Physician. 2012. Vol. 41, N 6. P. 366-370.
  4. Klimek, L. Management of anaphylaxis. Part 2. Treatment and emergency equipment / L. Klimek, U. Goebel, A. Glowania // HNO. 2012. Vol. 60, N 12. P. 1103-1113.
  5. Marrs, T. Why do few food-allergic adolescents treat anaphylaxis with adrenaline? - reviewing a pressing issue / T. Marrs, G. Lack // Pediatr. Allergy Immunol. 2012. Vol. 24. N 3. P. 222-229.
  6. Greenberger, P. A. Anaphylaxis. Ch. 24 / P. A. Greenberger, A. M. Ditto // Allergy and Asthma Proceedings / ed. by P. A. Greenberger, L. C. Grammer. 2012. Vol. 33, N 3, Suppl. 1. P. S80-S83.
  7. Epinephrine: The Drug of сhoice for anaphylaxis - a statement of the World Allergy Organization / F. Stephen [et al.] // World Allergy Organ. J. 2008. Vol.1, Suppl. 7. P. S18-S26.
  8. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community / A. Sheikh [et al.] // Cochrane Database Syst. Rev. 2012. Vol. 8
  9. Epinephrine auto-injector use and demographics in a Veterans Administration population / Ali Amirzadeh [et al.] // Allergy and Asthma Proceedings. 2010. Vol. 31, N 4. P. 304-307.
  10. Frew, A. J. What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? / A. J. Frew // Allergy. 2011.Vol. 66, N 1. P. 15-24.